Beclomethasone (generic), Vanceril, QVAR Newswire

Beclomethasone (generic), Vanceril, QVAR Newswire

Comprehensive Real-Time News Feed for Beclomethasone (generic), Vanceril, QVAR.

Results 1 - 20 of 162 in Beclomethasone (generic), Vanceril, QVAR

  1. Financial Contrast: SoligenixRead the original story w/Photo

    Saturday Dec 9 | IntersportsWire

    Soligenix and XOMA are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership. 2.1% of Soligenix shares are held by institutional investors.

    Comment?

  2. Contrasting VBI VaccinesRead the original story w/Photo

    Thursday Dec 7 | IntersportsWire

    VBI Vaccines and Soligenix are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. 21.0% of VBI Vaccines shares are held by institutional investors.

    Comment?

  3. Head-To-Head Analysis: XOMARead the original story w/Photo

    Tuesday Dec 5 | AmericanBankingNews.com

    XOMA and Soligenix are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. XOMA presently has a consensus target price of $28.50, suggesting a potential downside of 2.50%.

    Comment?

  4. Analyzing SoligenixRead the original story w/Photo

    Monday Dec 4 | Daily Political

    Soligenix and VBI Vaccines are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. 2.1% of Soligenix shares are owned by institutional investors.

    Comment?

  5. Soligenix Inc. (SNGX) Insider Acquires $622,241.20 in StockRead the original story w/Photo

    Monday Dec 4 | The Breeze

    Soligenix Inc. insider Spa Essetifin bought 293,510 shares of the firm's stock in a transaction dated Wednesday, November 29th. The stock was purchased at an average price of $2.12 per share, with a total value of $622,241.20.

    Comment?

  6. Financial Contrast: SoligenixRead the original story w/Photo

    Sunday Dec 3 | Daily Political

    Soligenix and ContraFect are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership. Soligenix currently has a consensus price target of $5.25, suggesting a potential upside of 152.40%.

    Comment?

  7. Critical Survey: VBI VaccinesRead the original story w/Photo

    Saturday Dec 2 | AmericanBankingNews.com

    VBI Vaccines and Soligenix are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership. VBI Vaccines has a beta of 3.73, meaning that its stock price is 273% more volatile than the S&P 500.

    Comment?

  8. Soligenix (SNGX) and ContraFect (CFRX) Head-To-Head ContrastRead the original story w/Photo

    Thursday Nov 30 | AmericanBankingNews.com

    Soligenix and ContraFect are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership. 2.1% of Soligenix shares are held by institutional investors.

    Comment?

  9. Reviewing SoligenixRead the original story w/Photo

    Tuesday Nov 28 | AmericanBankingNews.com

    Soligenix and Mirati Therapeutics are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. 2.1% of Soligenix shares are owned by institutional investors.

    Comment?

  10. Head-To-Head Survey: SoligenixRead the original story w/Photo

    Saturday Nov 25 | AmericanBankingNews.com

    Soligenix and Mirati Therapeutics are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends. Soligenix has higher revenue and earnings than Mirati Therapeutics.

    Comment?

  11. Critical Survey: SoligenixRead the original story w/Photo

    Thursday Nov 23 | AmericanBankingNews.com

    Soligenix and TetraLogic Pharmaceuticals Corporation are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability. This is a breakdown of recent ratings and target prices for Soligenix and TetraLogic Pharmaceuticals Corporation, as reported by MarketBeat.com.

    Comment?

  12. Soligenix (SNGX) Receives Daily News Impact Score of 0.28Read the original story w/Photo

    Monday Nov 20 | The Breeze

    News stories about Soligenix have trended positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources.

    Comment?

  13. Analyzing XOMA CorporationRead the original story w/Photo

    Sunday Nov 19 | AmericanBankingNews.com

    XOMA Corporation and Soligenix are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability. XOMA Corporation has a beta of 3.11, meaning that its share price is 211% more volatile than the S&P 500.

    Comment?

  14. Trillium Therapeutics (TRIL) vs. Soligenix (SNGX) Critical ComparisonRead the original story w/Photo

    Nov 14, 2017 | AmericanBankingNews.com

    Trillium Therapeutics and Soligenix are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends. Soligenix is trading at a lower price-to-earnings ratio than Trillium Therapeutics, indicating that it is currently the more affordable of the two stocks.

    Comment?

  15. Comparing SoligenixRead the original story w/Photo

    Nov 11, 2017 | IntersportsWire

    Soligenix and Grifols, are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability. Soligenix currently has a consensus price target of $8.00, suggesting a potential upside of 25.98%.

    Comment?

  16. Reviewing SoligenixRead the original story w/Photo

    Nov 10, 2017 | The Breeze

    Soligenix and Jazz Pharmaceuticals PLC are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. This is a summary of current ratings and price targets for Soligenix and Jazz Pharmaceuticals PLC, as provided by MarketBeat.

    Comment?

  17. -$0.32 Earnings Per Share Expected for Soligenix Inc. (SNGX) This QuarterRead the original story w/Photo

    Nov 9, 2017 | Daily Political

    Wall Street brokerages forecast that Soligenix Inc. will post earnings per share of for the current fiscal quarter, according to Zacks . Two analysts have made estimates for Soligenix's earnings, with the highest EPS estimate coming in at and the lowest estimate coming in at .

    Comment?

  18. Zacks Investment Research Research Analysts Increase Earnings Estimates for Soligenix Inc.Read the original story w/Photo

    Nov 9, 2017 | IntersportsWire

    Analysts at Zacks Investment Research boosted their FY2017 earnings estimates for Soligenix in a research report issued to clients and investors on Monday. Zacks Investment Research analyst G. Zeng now expects that the biopharmaceutical company will earn per share for the year, up from their previous forecast of .

    Comment?

  19. Financial Contrast: SoligenixRead the original story w/Photo

    Nov 8, 2017 | Daily Political

    Soligenix and Jazz Pharmaceuticals PLC are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership. Soligenix has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.

    Comment?

  20. Soligenix Inc. (SNGX) Expected to Post Quarterly Sales of $1.36 MillionRead the original story w/Photo

    Nov 8, 2017 | AmericanBankingNews.com

    Equities analysts expect Soligenix Inc. to report $1.36 million in sales for the current quarter, according to Zacks . Two analysts have made estimates for Soligenix's earnings.

    Comment?